1st Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$1,440,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

-Issues related to the NAFTA/USMCA renegotiation issues. -Issues related to new tariff proclamations and retaliation.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

- Issues related to miscellaneous tax bills. - Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to replacing G1LT1 global average method with a per country minimum. - Issues related to CFC look through. - Issues related to the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 - A bill to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements, regarding all provisions.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DARREL C JODREY —
DAVID KAVANAUGH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: S. 1089 (116th), S. 780 (116th), H.R. 1922 (116th), H.R. 1712 (116th), H.R. 1711 (116th), S. 779 (116th)

Health Issues HCR

- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - H.R. 269 - Pandemic and All-Hazards Preparedness & Advancing Innovation Act of 2019, regarding all provisions - Issues related to the reputation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to the medical device tax repeal - Issues related to medical product communications - Issues related to medical product review - Issues related to talc safety - Issues related to drug pricing reform - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
MICHAEL BARNARD —
LEIF BRIERLEY New Winston Health Policy Fellow, Office of Senator Michael Bennet, September 2014 - July 2015.
ANNE BRUCE —
LAURYL DODSON JACKSON —
DARREL C JODREY —
DAVID KAVANAUGH —
MEGHAN DRENAN STONE —
KELLY WATERS New Legislative Correspondent, Office of Congressman Leonard Lance, June 2014 - January 2017.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 863 (116th), H.R. 269 (116th), S. 726 (116th)

Veterans VET

-Issues regarding Healthy Heroes, partnership with the VA on Suicide Prevention, integrated marketing, clinical trials and personalized medicine. -Issues related to VA medical device procurement issues.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Medicare/Medicaid MMM

- Issues related to reimbursement

LobbyistCovered position, as disclosed
MICHAEL BARNARD —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

-Issues related to FY2020 Appropriations, specifically the Special Olympics, The Global Fund, Food & Drug Administration, Commerce, Interior, and Environmental Protection Agency budgets.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
MICHAEL BARNARD —
LAURYL DODSON JACKSON —
DARREL C JODREY —
MEGHAN DRENAN STONE —
KELLY WATERS —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

- Patent Trade Office reforms - H.R.1520-Purple Book Continuity Act of 2019, regarding all provisions - H.R.1503-Orange Book Transparency Act of 2019, regarding all provisions - H.R.1499-Protecting Consumer Access to Generic Drugs Act of 2019, regarding all provisions - S.649 -Biologic Patent Transparency Act, regarding all provisions.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 1503 (116th), H.R. 1499 (116th), S. 649 (116th), H.R. 1520 (116th)

Environment/Superfund ENV

- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions

LobbyistCovered position, as disclosed
DARREL C JODREY —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1834 (116th)

Torts TOR

- Issues related to civil justice reform.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.